Advancing Chelator Technologies for Enhanced Radiopharmaceutical Development
- Enhancing therapeutic performance by modifying drug properties for improved efficacy and safety
- Selecting optimal chelators to maximize stability and target delivery
- Optimizing pharmacokinetics and biodistribution to improve drug distribution and clearance for better clinical outcomes
New Company for 2026